These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 16087676)

  • 1. A novel form of neurotensin post-translationally modified by arginylation.
    Eriste E; Norberg A; Nepomuceno D; Kuei C; Kamme F; Tran DT; Strupat K; Jörnvall H; Liu C; Lovenberg TW; Sillard R
    J Biol Chem; 2005 Oct; 280(42):35089-97. PubMed ID: 16087676
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A post-translational modification of nuclear proteins, N(G),N(G)-dimethyl-Arg, found in a natural HLA class I peptide ligand.
    Yagüe J; Vázquez J; López de Castro JA
    Protein Sci; 2000 Nov; 9(11):2210-7. PubMed ID: 11152131
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Peptide backbone modifications on the C-terminal hexapeptide of neurotensin.
    Einsiedel J; Hübner H; Hervet M; Härterich S; Koschatzky S; Gmeiner P
    Bioorg Med Chem Lett; 2008 Mar; 18(6):2013-8. PubMed ID: 18276136
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Novel stable analogues of the neurotensin C-terminal hexapeptide containing unnatural amino acids.
    Magafa V; Matsoukas MT; Karageorgos V; Dermitzaki E; Exarchakou R; Stylos EΚ; Pardalos M; Margioris AN; Varvounis G; Tzakos AG; Spyroulias GA; Liapakis G
    Amino Acids; 2019 Jul; 51(7):1009-1022. PubMed ID: 31079216
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurotensin receptor-1 and -3 complex modulates the cellular signaling of neurotensin in the HT29 cell line.
    Martin S; Navarro V; Vincent JP; Mazella J
    Gastroenterology; 2002 Oct; 123(4):1135-43. PubMed ID: 12360476
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of neurotensin receptors in human corneal keratocytes.
    Bourcier T; Rondeau N; Paquet S; Forgez P; Lombet A; Pouzaud F; Rostène W; Borderie V; Laroche L
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1765-71. PubMed ID: 12036977
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular cloning and functional characterization of a type-I neurotensin receptor (NTR) and a novel NTR from the bullfrog brain.
    Li JH; Sicard F; Salam MA; Baek M; LePrince J; Vaudry H; Kim K; Kwon HB; Seong JY
    J Mol Endocrinol; 2005 Jun; 34(3):793-807. PubMed ID: 15956348
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evaluation of DOTA-chelated neurotensin analogs with spacer-enhanced biological performance for neurotensin-receptor-1-positive tumor targeting.
    Jia Y; Shi W; Zhou Z; Wagh NK; Fan W; Brusnahan SK; Garrison JC
    Nucl Med Biol; 2015 Nov; 42(11):816-23. PubMed ID: 26302836
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Neurotensin negatively modulates Akt activity in neurotensin receptor-1-transfected AV12 cells.
    Liu F; Yang P; Baez M; Ni B
    J Cell Biochem; 2004 Jun; 92(3):603-11. PubMed ID: 15156571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure and binding of specifically mutated neurotensin fragments on a silver substrate: vibrational studies.
    Podstawka-Proniewicz E; Kudelski A; Kim Y; Proniewicz LM
    J Phys Chem B; 2011 Jun; 115(21):7097-108. PubMed ID: 21548565
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Involvement of the neurotensin receptor subtype NTR3 in the growth effect of neurotensin on cancer cell lines.
    Dal Farra C; Sarret P; Navarro V; Botto JM; Mazella J; Vincent JP
    Int J Cancer; 2001 May; 92(4):503-9. PubMed ID: 11304684
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Structure-based exploration of an allosteric binding pocket in the NTS1 receptor using bitopic NT(8-13) derivatives and molecular dynamics simulations.
    Kling RC; Burchardt C; Einsiedel J; Hübner H; Gmeiner P
    J Mol Model; 2019 Jun; 25(7):193. PubMed ID: 31209646
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Post-translational arginylation of calreticulin: a new isospecies of calreticulin component of stress granules.
    Decca MB; Carpio MA; Bosc C; Galiano MR; Job D; Andrieux A; Hallak ME
    J Biol Chem; 2007 Mar; 282(11):8237-45. PubMed ID: 17197444
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification and functional characterization of a 5-transmembrane domain variant isoform of the NTS2 neurotensin receptor in rat central nervous system.
    Perron A; Sarret P; Gendron L; Stroh T; Beaudet A
    J Biol Chem; 2005 Mar; 280(11):10219-27. PubMed ID: 15637074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intermolecular interactions between the neurotensin and the third extracellular loop of human neurotensin 1 receptor.
    Da Costa G; Bondon A; Coutant J; Curmi P; Monti JP
    J Biomol Struct Dyn; 2013 Dec; 31(12):1381-92. PubMed ID: 23140271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The N-terminal neurotensin fragment, NT1-11, inhibits cortisol secretion by human adrenocortical cells.
    Sicard F; Contesse V; Lefebvre H; Ait-Ali D; Gras M; Cartier D; Decker A; Chartrel N; Anouar Y; Vaudry H; Delarue C
    J Clin Endocrinol Metab; 2006 Aug; 91(8):3131-7. PubMed ID: 16705076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Structure of monolayers formed from neurotensin and its single-site mutants: vibrational spectroscopic studies.
    Podstawka-Proniewicz E; Kudelski A; Kim Y; Proniewicz LM
    J Phys Chem B; 2011 May; 115(20):6709-21. PubMed ID: 21542591
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Agonism, inverse agonism, and neutral antagonism at the constitutively active human neurotensin receptor 2.
    Richard F; Barroso S; Martinez J; Labbé-Jullié C; Kitabgi P
    Mol Pharmacol; 2001 Dec; 60(6):1392-8. PubMed ID: 11723247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of the receptor subtype involved in the analgesic effect of neurotensin.
    Dubuc I; Sarret P; Labbé-Jullié C; Botto JM; Honoré E; Bourdel E; Martinez J; Costentin J; Vincent JP; Kitabgi P; Mazella J
    J Neurosci; 1999 Jan; 19(1):503-10. PubMed ID: 9870978
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Shedding of the luminal domain of the neurotensin receptor-3/sortilin in the HT29 cell line.
    Navarro V; Vincent JP; Mazella J
    Biochem Biophys Res Commun; 2002 Nov; 298(5):760-4. PubMed ID: 12419319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.